Virtus LifeSci Biotech Products ETF Rating $101.80 +1.09 (+1.08%) Closing price 04:10 PM EasternExtended Trading$101.80 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsNews and TrendsOwnershipRatingsShort Interest Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.61Holdings in BBP have an aggregate rating of Moderate Buy based on 334 analyst ratings issued in the past year covering 25 companies (51.3% of the portfolio).BBP Aggregate Price Target$101.80High Prediction$101.80Average Prediction$101.80Low Prediction$101.80Holdings in BBP have an aggregate price target of $101.80 and a range of $101.80 to $101.80 covering 25 companies (51.3% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings5.31%MRNAModerna$226.30+4.6%Hold$100.60 -55.5%261.7591 of 5 starsTrending News4.52%IOVAIovance Biotherapeutics$14.21-2.0%Moderate Buy$13.20 -7.1%132.0778 of 5 starsAnalyst Forecast2.82%OMEROmeros$18.43-2.4%Moderate Buy$34.00 84.5%73.773 of 5 starsAnalyst Forecast2.55%VSTMVerastem$7.71+3.5%Moderate Buy$14.67 90.2%123.5539 of 5 starsTrending NewsAnalyst ForecastGap UpTrading HaltedHigh Trading Volume2.27%PGENPrecigen$7.36-1.6%Moderate Buy$13.67 85.7%63.6432 of 5 stars2.03%HALOHalozyme Therapeutics$116.82+6.6%Moderate Buy$96.50 -17.4%123.4415 of 5 starsAnalyst Forecast1.96%ZLABZai Lab$22.50-2.6%Moderate Buy$37.25 65.6%72.7117 of 5 starsNews CoverageGap Down1.95%XERSXeris Biopharma$9.77-4.2%Hold$13.20 35.1%74.2511 of 5 stars1.92%KNSAKiniksa Pharmaceuticals International$78.84+0.4%Moderate Buy$93.14 18.1%94.1084 of 5 stars1.91%IBRXImmunityBio$9.91+1.1%Moderate Buy$16.00 61.5%73.0979 of 5 starsNews CoverageAnalyst ForecastHigh Trading Volume1.90%RIGLRigel Pharmaceuticals$46.82-0.7%Moderate Buy$59.00 26.0%74.5098 of 5 stars1.85%NVAXNovavax$12.64-1.4%Hold$14.00 10.8%91.8007 of 5 stars1.78%ONCBeOne Medicines$351.48+0.7%Buy$404.93 15.2%173.9328 of 5 stars1.67%PTGXProtagonist Therapeutics$136.28-1.6%Buy$154.44 13.3%181.9656 of 5 starsNews CoverageAnalyst Forecast1.61%ADMAADMA Biologics$10.34+0.3%Moderate Buy$18.67 80.5%63.9085 of 5 stars1.57%LGNDLigand Pharmaceuticals$294.99-2.8%Buy$337.89 14.5%104.0475 of 5 stars1.57%TARSTarsus Pharmaceuticals$72.29+2.1%Moderate Buy$100.86 39.5%103.5408 of 5 stars1.55%REGNRegeneron Pharmaceuticals$778.36+3.4%Moderate Buy$834.24 7.2%314.521 of 5 starsPositive News1.55%ROIVRoivant Sciences$33.62+0.8%Moderate Buy$45.64 35.7%142.7137 of 5 starsAnalyst Downgrade1.53%KURAKura Oncology$9.61-2.2%Moderate Buy$25.35 163.8%133.5343 of 5 starsAnalyst Forecast1.51%HRMYHarmony Biosciences$37.51+1.3%Hold$47.44 26.5%114.6248 of 5 starsAnalyst Forecast1.50%CRSPCRISPR Therapeutics$50.22+0.2%Moderate Buy$67.50 34.4%193.4398 of 5 stars1.50%GILDGilead Sciences$153.54+3.8%Moderate Buy$159.33 3.8%293.2204 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision1.49%SRPTSarepta Therapeutics$16.83+1.9%Reduce$22.59 34.2%213.3498 of 5 starsAnalyst Upgrade1.49%ZYMEZymeworks$24.77-1.2%Moderate Buy$40.64 64.1%132.8037 of 5 stars This page (NYSEARCA:BBP) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a...Crypto 101 Media | SponsoredElon pays this company. Every time.Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBP Stock Alerts